logo

For the Inventor, By the Inventor

Oxford, United Kingdom

Fiona Margaret Ellard

This inventor holds 10 USPTO granted patents and 2 published patent applications. Top assignees: Oxford Biomedica (UK) Limited, Oxford Biomedica, Inc., The University of North Carolina at Chapel Hill. Active years: 2004-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fiona Margaret Ellard. Retrieved from https://idiyas.com/inventor/fiona-margaret-ellard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 50.0

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 54(Granted Patents)


Location History:

  • Berkshire, GB (2005)
  • Reading, GB (2005 - 2010)
  • Oxford, GB (2004 - 2011)

Company Filing History:

goldMedal9 out of 53 
 
Oxford Biomedica (UK) Limited
 patents
silverMedal1 out of 5 
 
Oxford Biomedica, Inc.
 patents
bronzeMedal1 out of 1,329 
 
The University of North Carolina at Chapel Hill
 patents
where one patent can have more than one assignee

Years Active: 2004-2011

Loading Chart...
10 patents (USPTO):Explore Patents
1. 8084249 - Vector (2011-12-27),
2. 7718627 - Vector (2010-05-18),
3. 7635687 - Vector system (2009-12-22),
4. 7531648 - Vector encoding an antibody that binds 5T4 antigen (2009-05-12),
5. 7514546 - Antibodies (2009-04-07),
6. 7276488 - Vector system (2007-10-02),
7. 7074909 - Antibodies (2006-07-11),
8. 6969598 - Methods for producing high titre vectors and compositions used in such methods (2005-11-29),
9. 6852703 - Tumor targeted vector (2005-02-08),
10. 6818209 - Retroviral delivery system (2004-11-16),

Title: Fiona Margaret Ellard: Innovator in Tumor-Targeting Vectors

Introduction

Fiona Margaret Ellard is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of biotechnology, particularly in the development of vectors that target tumors. With a total of 10 patents to her name, her work has the potential to revolutionize cancer treatment.

Latest Patents

Among her latest innovations is a vector comprising a nucleotide sequence of interest (NOI) that encodes a product of interest (POI). This vector is designed to recognize tumors, allowing for the targeted delivery of the NOI and/or the POI directly to the tumor site. This innovative approach could enhance the effectiveness of cancer therapies.

Career Highlights

Fiona has worked with notable organizations, including Oxford Biomedica Limited and the University of North Carolina at Chapel Hill. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Fiona has collaborated with esteemed colleagues such as Christopher Robert Bebbington and Kevin Alan Myers. These partnerships have further enriched her research and development efforts in the biotechnology sector.

Conclusion

Fiona Margaret Ellard's work in developing tumor-targeting vectors showcases her innovative spirit and dedication to advancing cancer treatment. Her contributions to biotechnology are invaluable and continue to inspire future research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…